Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients

G Careaga, D Salazar, S Téllez, O Sánchez… - Archives of medical …, 2001 - Elsevier
BACKGROUND: Ischemia-reperfusion injury during open heart surgery related to
unsuccessful myocardial protection may increase morbidity or mortality. We analyze the …

The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery

J Liu, Z Feng, J Zhao, B Li, C Long - Asaio Journal, 2008 - journals.lww.com
Cardioplegic reperfusion during a long term ischemic period interrupts cardiac surgery and
also increase cellular edema due to repeated administration. We reviewed the clinical …

[HTML][HTML] Intestinal injury can be reduced by intra-arterial postischemic perfusion with hypertonic saline

O Kornyushin, M Galagudza, A Kotslova… - World Journal of …, 2013 - ncbi.nlm.nih.gov
AIM: To investigate the effect of local intestinal perfusion with hypertonic saline (HTS) on
intestinal ischemia-reperfusion injury (IRI) in both ex vivo and in vivo rat models. METHODS …

La experiencia adquirida a 34 años del primer trasplante de corazón en México

G Careaga-Reyna - Gaceta médica de México, 2023 - scielo.org.mx
El 21 de julio de 1988, en México se realizó con éxito el primer trasplante de corazón; 34
años después, diversos centros hospitalarios del país efectúan este procedimiento. Aquí se …

Trasplante de corazón. Preservación y técnica quirúrgica. Once años de experiencia

G Careaga-Reyna, M Jiménez-Valdivia… - Revista de …, 2005 - medigraphic.com
Antecedentes. El trasplante de corazón es la modalidad de tratamiento que ha modificado
sustancialmente la expectativa de vida en pacientes con insuficiencia cardiaca terminal. El …

Effect on acute rejection reaction and survival of the heart with the addition of dextran 60 to conventional immunosuppressive therapy in an experimental model of …

G Careaga-Reyna, RS Argüero - Archives of Medical Research, 2000 - Elsevier
BACKGROUND: Rejection reaction is an important complication in heart transplantation.
Recent physiopathological findings suggest new immunosuppressive alternatives such as …

Histidine-tryptophan-ketoglutarate versus blood cardioplegic solutions: a prospective, myocardial ultrastructural study

SH Kim, YS Lee, JS Woo, SC Sung, PJ Choi… - Journal of Chest …, 2007 - koreascience.kr
Background: We performed a prospective clinical study to evaluate the ultrastructural
integrity of the myocardium after using Histidine-Tryptophan-Ketoglutarate (HTK) solution in …

Assessment of the effect of adding a mid-molecular weight (130 kDa) starch to the priming solution for the circuit of the extracorporeal circulation machine on …

GC Reyna, VMC Delgado, LEM Concebida… - Cirujano …, 2006 - medigraphic.com
Objective: To assess alterations in coagulation, perioperative bleeding, and hemodynamic
response with the use of a mid-molecular weight (130 kDa) pentastarch in the priming …

A comparison of the effects of histidine-tryptophan-ketoglutarate solution versus cold blood cardioplegic solution on myocardial protection in mitral valve surgery

YS Choi, SO Bang, BC Chang, S Lee… - Journal of Chest …, 2007 - koreascience.kr
Background: lschemia-reperfusion injury related to unsuccessful myocardial protection
affects postoperative ventricular function and mortality during open-heart surgery. We …

승모판막수술시히스티딘를함유한결정성심정지액(Histidine-tryptophan-ketoglutarate Solution) 과저온혈성심정지액이심근기능보존에미치는영향비교

최용선, 방서욱, 장병철, 이삭, 박철희… - 大韓胸部外科學會誌, 2007 - kiss.kstudy.com
배경: 개심술 시 불충분한 심근 보호로 인한 허혈과 재관류 손상은 술 후 심실 기능과 예후에
영향을 미친다. 본 저자들은 승모판막 수술에서 HTK 용액과 냉혈 혈성 심정지액이 심근 보호와 …